Cargando…

The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study

BACKGROUND: Many patients with schizophrenia discontinue antipsychotic medication, frequently with adverse outcomes. Although different antipsychotic formulations are associated with different times to discontinuation, not much is known about discontinuation rates with oral-weekly formulations. Such...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Lee, Arnold P. M., Önsesveren, Ibrahim, Wierdsma, André I., van Westrhenen, Roos, Beekman, Aartjan T. F., de Haan, Lieuwe, Mulder, Niels C. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068711/ https://www.ncbi.nlm.nih.gov/pubmed/33837915 http://dx.doi.org/10.1007/s40263-021-00802-3

Ejemplares similares

Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal cohort study
por: van der Lee, Arnold P. M., et al.
Publicado: (2021)

Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs
por: van der Lee, Arnold, et al.
Publicado: (2016)

Rising co-payments and continuity of healthcare for Dutch patients with bipolar disorder: retrospective longitudinal cohort study
por: van der Lee, Arnold P. M., et al.
Publicado: (2021)

Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands
por: van der Lee, Arnold P. M., et al.
Publicado: (2019)

T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bogers, Jan, et al.
Publicado: (2020)

The Amsterdam Studies of Acute Psychiatry I (ASAP-I); A prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan area
por: van der Post, Louk, et al.
Publicado: (2008)

Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board
por: Storosum, Bram W. C., et al.
Publicado: (2023)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
por: Luykx, Jurjen J., et al.
Publicado: (2020)

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
por: Moncrieff, Joanna, et al.
Publicado: (2019)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Correction: Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
Publicado: (2020)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu, Xiaoli, et al.
Publicado: (2014)

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020)

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
por: Hatano, Masakazu, et al.
Publicado: (2021)

Measurement invariance of the center for epidemiological studies depression scale (CES-D) among chinese and dutch elderly
por: Zhang, Baoshan, et al.
Publicado: (2011)

META-ANALYSES ON DOUBLE-BLIND RCTS ADDING DRUGS WITH ANTI-INFLAMMATORY PROPERTIES TO ANTIPSYCHOTIC MEDICATION
por: Sommer, Iris, et al.
Publicado: (2014)

Ten-year trends in benzodiazepine use in the Dutch population
por: Sonnenberg, Caroline M., et al.
Publicado: (2011)

Support staff’s perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed‐method study
por: Kleijwegt, Bas, et al.
Publicado: (2019)

F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
por: Bogers, Jan, et al.
Publicado: (2018)

Predictors of successful discontinuation of antipsychotics and antidepressants
por: Lincoln, Tania M., et al.
Publicado: (2023)

Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
por: Mahlich, Jörg, et al.
Publicado: (2020)

A Visual Metaphor Describing Neural Dynamics in Schizophrenia
por: van Beveren, Nico J. M., et al.
Publicado: (2008)

Comparison of Olanzapine versus Other Second-Generation Antipsychotics in the Improvement of Insight and Medication Discontinuation Rate in Schizophrenia
Publicado: (2018)

Discussing suicidality with depressed patients: an observational study in Dutch sentinel general practices
por: Elzinga, Elke, et al.
Publicado: (2019)

Dutch Brain Research Registry for study participant recruitment: Design and first results
por: Zwan, Marissa D., et al.
Publicado: (2021)

An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders
por: Crellin, Nadia E., et al.
Publicado: (2022)

Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10
por: Tatini, Lorenzo, et al.
Publicado: (2021)

Clinical profiles of subsequent stages in bipolar disorder: Results from the Dutch Bipolar Cohort
por: van der Markt, Afra, et al.
Publicado: (2021)

Dutch Mental Health Patients’ and Significant Others’ Perspectives on Compulsory Treatment at Home: One Size Does Not Fit All
por: de Waardt, DA, et al.
Publicado: (2021)

Evaluation of a Collaborative Care Program for Patients With Treatment-Resistant Schizophrenia: Protocol for a Multiple Case Study
por: Jongkind, Amy, et al.
Publicado: (2022)

Burying Our Heads in the Sand: The Neglected Importance of Reporting Inter-Rater Reliability in Antipsychotic Medication Trials
por: Berendsen, Steven, et al.
Publicado: (2020)

O11.3. A LONGITUDINAL ANALYSIS OF THE EFFECTS OF NEUROTICISM AND EXTRAVERSION ON SUBJECTIVE WELL-BEING IN PATIENTS WITH SCHIZOPHRENIA
por: van Dijk, Floor, et al.
Publicado: (2018)

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics
por: Stam, Noraly, et al.
Publicado: (2020)

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies
por: Mathews, Maju, et al.
Publicado: (2020)

Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation
por: Correll, Christoph U, et al.
Publicado: (2019)

Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation
por: Cooper, Ruth E., et al.
Publicado: (2019)

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
por: Kishi, Taro, et al.
Publicado: (2021)

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study
por: Hishimoto, Akitoyo, et al.
Publicado: (2022)

Risk factors for psychotic relapse in chronic schizophrenia after dose-reduction or discontinuation of antipsychotics. A systematic review and meta-analysis
por: Bogers, J., et al.
Publicado: (2021)

Pharmacogenomics and the Management of Mood Disorders—A Review
por: Kleine Schaars, Kristian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kgmdlo2ai0cjcaqfm809neslkf